User contributions
From 2010.igem.org
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 03:50, 27 October 2010 (diff | hist) Team:Kyoto/Project (→Goal A: Characterization of R0011, a strong lactose promoter)
- 03:49, 27 October 2010 (diff | hist) Team:Kyoto/Project (→2. Solution to the Restriction on Promoter's Activity)
- 03:46, 27 October 2010 (diff | hist) Team:Kyoto/Project (→Background)
- 03:42, 27 October 2010 (diff | hist) Team:Kyoto/Project (→Background)
- 23:20, 26 October 2010 (diff | hist) Team:Kyoto/Safety (→4. Other Ideas)
- 23:19, 26 October 2010 (diff | hist) Team:Kyoto/Safety (→3. Safety Rules)
- 15:06, 26 October 2010 (diff | hist) Team:Kyoto/LearnMore (→Lysis system)
- 15:05, 26 October 2010 (diff | hist) Team:Kyoto/LearnMore (→λ phage)
- 15:01, 26 October 2010 (diff | hist) Team:Kyoto/LearnMore (→λ phage)
- 15:00, 26 October 2010 (diff | hist) Team:Kyoto/LearnMore (→λ phage)
- 14:58, 26 October 2010 (diff | hist) Team:Kyoto/LearnMore (→Lac promoter of lambda phage)
- 03:40, 26 October 2010 (diff | hist) Team:Kyoto/HumanPractice (→Results)
- 03:39, 26 October 2010 (diff | hist) Team:Kyoto/HumanPractice (→Results)
- 03:39, 26 October 2010 (diff | hist) Team:Kyoto/HumanPractice (→Advantages)
- 03:38, 26 October 2010 (diff | hist) Team:Kyoto/HumanPractice (→Introduction)
- 03:37, 26 October 2010 (diff | hist) Team:Kyoto/HumanPractice (→Questionnaire)
(Latest | Earliest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)